Generic Drug Market Opportunities in Ghana: Expired Registrations Analysis 2026
Analysis of 40 expired drug registrations in Ghana by 2026, revealing key generic entry points in anti-infectives, cardiovascular, and pain management.
An analysis of recently expired drug registrations in the Ghanaian pharmaceutical market reveals 40 products across various therapeutic areas expiring by September 2026. This presents a significant window of opportunity for generic manufacturers seeking to enter or expand their footprint in West Africa.
AfriReg’s intelligence platform has identified these registrations, offering a data-backed perspective on potential generic market entry points. The bulk of these expirations are concentrated in Anti-infectives (antibiotics, antifungals, antimalarials, antivirals), followed by Cardiovascular drugs and Pain/Inflammation management.
Key Therapeutic Areas for Generic Opportunity
Anti-infectives: A Dominant Sector
The largest number of expiring registrations fall within the anti-infective category, highlighting sustained demand and potential for competitive generic offerings. Key molecules include:
- Amoxicillin/Potassium Clavulanate (Co-amoxiclav): This widely used antibiotic combination sees multiple formulations (625mg tablets, 1g tablets, 457mg suspension) with expired registrations. This indicates a high-volume market with established prescribing patterns, making it a prime target for generic entry. Brands like MYCLAV 625, LAVI-CV 625, CLAVU-NOVA, and CLAVUNOVA are among those with expiring entries.
- Artemether/Lumefantrine: As a first-line treatment for uncomplicated malaria, several formulations (20mg/120mg tablets, 40/240mg DS, general tablets) have expiring registrations. This ensures continued market demand in malaria-endemic regions like Ghana. NOVAMETHER and POMEX registered products present opportunities.
- Ciprofloxacin: A broad-spectrum antibiotic, 500mg tablet formulations (GEBECIP) also show expired registrations, offering further scope for generic competition in bacterial infection management.
- Azithromycin: An oral suspension product has an expired registration, pointing to an opportunity in managing various bacterial infections, particularly where oral suspensions are preferred (e.g., pediatrics).
- Benzylpenicillin/Benzathine Benzylpenicillin: Multiple injectable penicillin formulations (1 MEGA, 1.2G) have expired registrations, serving as essential medicines for severe bacterial infections.
- Cefuroxime: An injection formulation (CEFOSON) has an expired registration, indicating an avenue for generic versions of this important cephalosporin antibiotic.
- Abacavir/Lamivudine: The fixed-dose combination for HIV treatment (600mg/300mg tablets) represents a critical public health opportunity for generic manufacturers to improve access and affordability.
Cardiovascular Health: Essential Medications
Amlodipine Besylate, a common calcium channel blocker for hypertension, appears twice with expiring registrations (TEVRALEX TABLET and TEVRALEX TABLETS 10mg). This suggests a consistent need for anti-hypertensive medications in the market, providing scope for generic versions to increase patient access and reduce healthcare costs.
Pain and Inflammation Management: High Consumer Demand
- Aceclofenac/Paracetamol: A combination product for pain and inflammation (ACLO-P TABLETS) has an expired registration, indicating a robust market for analgesic and anti-inflammatory drugs.
- Aceclofenac: A standalone 100mg tablet (ZULU-100 TABLETS) also shows an expired registration, reinforcing the potential for generic competition in this area.
- Acetaminophen (Paracetamol): A suppository formulation (SKYPARA 250mg) has an expired registration, providing an opportunity for generic versions, especially useful in pediatric care or when oral administration is difficult.
Other Notable Opportunities
- Betamethasone combinations: Several topical creams combining Betamethasone with antibacterials and antifungals (EMI CREAM, AMIDERM CREAM, ESKYZOLE CREAM) have expired registrations. These are commonly used for inflammatory skin conditions often complicated by infection.
- Artesunate/Arginine/Sodium bicarbonate: An injectable co-pack (ARGESUN INJECTION) for severe malaria indicates a need for generic alternatives that could significantly impact public health initiatives.
- Aluminium Hydroxide/Magnesium Hydroxide/Oxetacaine: An antacid suspension (BLUGEL-O SUSPENSION) points to continued demand for gastrointestinal remedies.
- Herbal Preparations: Multiple herbal medicines with expired registrations (e.g., BOAMAH OINTMENT, TINARQ OINTMENT, APDYL- H COUGH SYRUP, DYNAMIC HERBAL OINTMENT, MARY OYE MAAME BALM, ABBOR OINTMENT) highlight a parallel traditional medicine market that could see new generic herbal entries or updated traditional product registrations.
Detailed List of Expired Registrations in Ghana (2026)
| Drug | Original Holder | Country | Expired Date |
|---|---|---|---|
| Abamata Ginger Powder(PET) (Abamata Ginger Powder(PET)) | — | Ghana | 02 Sept 2026 |
| Abamata Ginger & Garlic Powder(PET) (Abamata Ginger & Garlic Powder(PET)) | — | Ghana | 02 Sept 2026 |
| GEBECIP 0.3% (CIPROFLOXACIN) | GB PHARMA LIMITED, 65 CHATSWORTH ROAD LONDON NW2 4BG UNITED KINGDOM | Ghana | 01 Sept 2026 |
| Banquet D'or Choco Coco Cake & Banquet D'or Double Choco Dome Cake (Banquet D'or Choco Coco Cake & Banquet D'or Double Choco Dome Cake) | — | Ghana | 01 Sept 2026 |
| EMI CREAM (Betamethasone/Gentamycin /Tolnaftate/Iodochlohydroxygunoline) | — | Ghana | 01 Sept 2026 |
| ZINFORO (CETAROLINE FOSAMIL) | PFIZER SPECIALITIES LIMITESD 7TH FLOOR 21 LUGGARD V IKOYI LAGOS NIGERIA | Ghana | 01 Sept 2026 |
| AZITRO ORAL SUSPENSION (Azithromycin) | — | Ghana | 01 Sept 2026 |
| BOAMAH OINTMENT (Allium sativum, Tetrapleura tetraptera, Ocimum gratissimum, Ocimum canum, Vitellaria paradoxa) | — | Ghana | 01 Sept 2026 |
| NOVAMETHER TABLETS (Each dispersible tablet contains Artemether/ Lumefantrine – 20mg/ 120mg) (Artemether/ Lumefantrine) | — | Ghana | 01 Sept 2026 |
| TINARQ OINTMENT (Aframomum melegueta, Zingiber officinale, Paullinia pinnata, Zanthoxylum zanthoxyloides) | — | Ghana | 01 Sept 2026 |
| AMIDERM CREAM (Betamethasone Valerate/ Gentamicin Sulphate/ Tolnaftate /Clioquinol) | GB PHARMA LIMITED, 65 CHATSWORTH ROAD LONDON NW2 4BG UNITED KINGDOM | Ghana | 01 Sept 2026 |
| ESKYZOLE CREAM (Betamethasone dipropionate/Clotrimazole/Gentamicin Sulfate) | — | Ghana | 01 Sept 2026 |
| MYCLAV 625 TABLETS (Each tablet contains Amoxicillin trihydrate / Potassium clavulanate 625mg) (Amoxicillin Trihydrate / Potassium Clavulanate) | — | Ghana | 01 Sept 2026 |
| CEFOSON INJECTION (CEFUROXIME) | — | Ghana | 01 Sept 2026 |
| NOVAMETHER 40/240 DS (ARTEMETHER/LUMEFANTRINE) | SKANT HEALTHCARE LIMITED 31 SHIV SAGAR ESTATE NORTH WING DR ANNIE BESANT ROAD WORLI MUMBAI 400018 INDIA | Ghana | 01 Sept 2026 |
| ABACAVIR/ LAMIVUDINE TABLETS (Each tablet contains Abacavir Sulfate/Lamivudine 600mg/300mg) (Abacavir Sulfate/Lamivudine) | — | Ghana | 01 Sept 2026 |
| TEVRALEX TABLET (Amlodipine besylate) | NORTHLAND BIOSCIENCE; 545 LANSING AVE STE 2, JACKSON, MI 49201, UNITED STATES | Ghana | 01 Sept 2026 |
| ARGESUN INJECTION (Each co-pack contains Artesunate/ Arginine/ Sodium bicarbonate-60mg/ 20mg/ml/ 8.4mg/ml Artesunate/ Arginine/ Sodium bicarbonate 60mg/ 20mg/ml/ 8.4mg/ml) (Artesunate/ Arginine/ Sodium bicarbonate) | — | Ghana | 01 Sept 2026 |
| SKYPARA 250mg SUPPOSITORY (Acetaminophen) | — | Ghana | 01 Sept 2026 |
| LAVI-CV 625 TABLETS (Amoxicillin Trihydrate / Potassium Clavulanate) | LAVINA PHARMACEUTICALS PVT. LIMITED, SATRA PLAZA, OFFICE NO.402 PLOT NO. 19-20, SECTOR-19 D, PALM BEACH RD, NAVI MUMBAI, MAHARASHTRA 400703, INDIA | Ghana | 01 Sept 2026 |
| APDYL- H COUGH SYRUP (Adhatoda vasika, Glycyrrhiza glabra, Piper longum, Alpinia galanga) | — | Ghana | 01 Sept 2026 |
| VISIONOL EYE DROPS (ACARBOSE) | GB PHARMA LIMITED, 65 CHATSWORTH ROAD LONDON NW2 4BG UNITED KINGDOM | Ghana | 01 Sept 2026 |
| VICTOZA 6MG/3ML (6MG/ML) | — | Ghana | 01 Sept 2026 |
| POMEX TABLETS (Artemether/Lumefantrine) | — | Ghana | 01 Sept 2026 |
| CLAVU-NOVA 625 TABLETS (Amoxicillin Sodium/Potassium Clavulanate) | — | Ghana | 01 Sept 2026 |
| TEVRALEX TABLETS (Each tablet contains Amlodipine Besylate 10mg) (Amlodipine besylate) | — | Ghana | 01 Sept 2026 |
| DYNAMIC HERBAL OINTMENT (Alstonia boonei, Moringa oleifera and Paullinia pinnata) | — | Ghana | 01 Sept 2026 |
| MARY OYE MAAME BALM (Allium sativum, Xylopia aethiopica and Tetrapleura tetraptera) | — | Ghana | 01 Sept 2026 |
| BLUGEL-O SUSPENSION (Each 15ml contains Aluminium Hydroxide/Magnesium Hydroxide/Oxetacaine 250mg/250mg/10mg) (Aluminium Hydroxide/Magnesium Hydroxide/Oxetacaine) | — | Ghana | 01 Sept 2026 |
| CLAVUNOVA 457MG SUSPENSION (Amoxicillin Trihydrate / Potassium Clavulanat) | — | Ghana | 01 Sept 2026 |
| POMEX TABLET (Artemether/Lumefantrine) | — | Ghana | 01 Sept 2026 |
| BENZYLPENICILLIN INJECTION (1MEGA) (BENZYLPENICILLIN INJECTION (1MEGA)) | — | Ghana | 01 Sept 2026 |
| BENTARIX-1.2 INJECTION (Each vial contains Benzathine Benzylpenicillin 1.2G) (Benzathine Benzylpenicillin) | — | Ghana | 01 Sept 2026 |
| ACLO-P TABLETS (Each film coated tablet contains Aceclofenac / Paracetamol 100mg/ 500mg) (Aceclofenac / Paracetamol) | — | Ghana | 01 Sept 2026 |
| ZULU-100 TABLETS (Each tablet contains Aceclofenac 100mg) (Aceclofenac) | — | Ghana | 01 Sept 2026 |
| ABBOR OINTMENT (Allium sativum, Tetrapleura tetraptera, Ocimum gratissimum, Ocimum canum, Vitellaria paradoxa) | — | Ghana | 01 Sept 2026 |
| FORTIFIED PROCAINE BENZYL PENICILLIN POWDER FOR INJECTION (1 MEGA) (Artemether/ Lumefantrine) | — | Ghana | 01 Sept 2026 |
| CLAVUNOVA SUSPENSION (Amoxicillin Trihydrate / Potassium Clavulanate) | — | Ghana | 01 Sept 2026 |
| CLAVU-NOVA 1G TABLETS (AMOXICILLIN / CLAVULANIC) | — | Ghana | 01 Sept 2026 |
| GEBECIP TABLETS (Each film coated tablet contains Ciprofloxacin 500mg) (CIPROFLOXACIN) | — | Ghana | 01 Sept 2026 |
Strategic Considerations for Generic Manufacturers
For generic pharmaceutical companies, these expiring registrations in Ghana represent actionable intelligence. Identifying registrations with no clearly established current alternatives from the original holder, or those where the original holder has a limited market presence, further enhances the opportunity.
Furthermore, assessing the broader market size for these molecules, local manufacturing capabilities, and import regulations will be crucial for a successful market entry strategy. The expiration of multiple formulations for key drugs like Amoxicillin/Clavulanate and Artemether/Lumefantrine suggests a robust and segmented demand, offering flexibility for generic developers to target specific dosage forms or patient populations.
The AfriReg Pro Advantage
AfriReg Pro automates the tracking of drug registrations, expirations, and regulatory changes across African markets. This capability provides regulatory teams with a proactive stance, enabling them to identify generic market entry points, monitor competitor lifecycles, and streamline their market access strategies with high-precision, real-time data, eliminating manual tracking and reducing risk.